TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 23, No. 19 October 1, 2017
_________________________________
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 23, No. 19 October 1, 2017
(The next issue will be on October 18, 2017)
TRIGGER is also available by RSS Feed
and BLOG.
_________________________________
UPCOMING MEETINGS EVENTS
For general info on upcoming meetings of interest, click here.
ISTH also maintains a list of upcoming meetings of interest: Click here.
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
Arderiu G, Espinosa S, Pena E, Aledo R, Badimon L (2016)
PAR2-SMAD3 in microvascular endothelial cells is indispensable for vascular
stability via tissue factor signaling. J Mol Cell Biol 8:255-270.
Barska K, Kwiatkowska W, Knysz B, Arczynska K, Karczewski
M, Witkiewicz W (2017) The role of the tissue factor and its inhibitor in the
development of subclinical atherosclerosis in people living with HIV. PLoS One
12:e0181533.
Bern MM (2017) Extracellular vesicles: how they interact
with endothelium, potentially contributing to metastatic cancer cell implants.
Clin Transl Med 6:33.
Calmette L, Martin AC, Le Bonniec B, Zlotnik D,
Gouin-Thibault I, Bachelot-Loza C, . . . Godier A (2017) Ticagrelor reversal:
in vitro assessment of four haemostatic agents. J Clin Pathol 70:733-739.
Chai-Adisaksopha C, Nevitt SJ, Simpson ML, Janbain M,
Konkle BA
(2017) Bypassing agent prophylaxis in people with
hemophilia A or B with inhibitors. Cochrane Database Syst Rev 9:CD011441.
Chan JL, Singh AK, Corcoran PC, Thomas ML, Lewis BG,
Ayares DL, . . .
Mohiuddin MM (2017) Encouraging experience using
multi-transgenic xenografts in a pig-to-baboon cardiac xenotransplantation
model.
Xenotransplantation.
Chandrashekar V (2017) Simplified Method for Local
Correction of System International Normalized Ratio. Lab Med 48:244-248.
Dambrauskiene R, Gerbutavicius R, Ugenskiene R,
Jankauskaite R, Savukaityte A, Simoliuniene R, . . . Juozaityte E (2017) Genetic
Polymorphisms of Hemostatic Factors and Thrombotic Risk in Non BCR-ABL
Myeloproliferative Neoplasms: A Pilot Study. Balkan J Med Genet 20:35-42.
De Paula VS, Silva FHS, Francischetti IMB, Monteiro RQ,
Valente AP
(2017) Recombinant expression of Ixolaris, a Kunitz-type
inhibitor from the tick salivary gland, for NMR studies. Protein Expr Purif
139:49-56.
de Sousa Bomfim A, de Freitas MCC, Covas DT, de Sousa
Russo EM (2018) Human Cells as Platform to Produce Gamma-Carboxylated Proteins.
Methods Mol Biol 1674:49-61.
Ettelaie C, Collier MEW, Featherby S, Greenman J,
Maraveyas A (2017) Peptidyl-prolyl isomerase 1 (Pin1) preserves the
phosphorylation state of tissue factor and prolongs its release within
microvesicles.
Biochim Biophys Acta.
Falanga A, Russo L, Milesi V, Vignoli A (2017) Mechanisms
and risk factors of thrombosis in cancer. Crit Rev Oncol Hematol 118:79-83.
Flannery AH, Pandya K, Laine ME, Almeter PJ, Flynn JD
(2017) Managing the Rising Costs and High Drug Expenditures in Critical Care
Pharmacy Practice. Pharmacotherapy 37:54-64.
Gao S, Lin Z, Li C, Wang Y, Yang L, Zou B, . . . Liu G
(2017) TFPI2AS1, a novel lncRNA that inhibits cell proliferation and migration
in lung cancer. Cell Cycle:1-10.
Grandone E, Chinni E, Villani M, Scianname N, Tiscia GL,
Favuzzi G, .
. . Margaglione M (2016) Modulation of factors involved
in placental haemostasis and angiogenesis by low-molecular-weight-heparins.
Arch Gynecol Obstet 294:1323-1329.
Granovski V, Freitas MCC, Abreu-Neto MS, Covas DT (2018)
Purification and Autoactivation Method for Recombinant Coagulation Factor VII.
Methods Mol Biol 1674:221-226.
Gussregen S, Matter H, Hessler G, Lionta E, Heil J, Kast
SM (2017) Thermodynamic Characterization of Hydration Sites from Integral
Equation-Derived Free Energy Densities: Application to Protein Binding Sites
and Ligand Series. J Chem Inf Model 57:1652-1666.
Huang J, Tian R, Yang Y, Jiang R, Dai J, Tang L, Zhang L
(2017) The
SIRT1 inhibitor EX-527 suppresses mTOR activation and
alleviates acute lung injury in mice with endotoxiemia. Innate
Immun:1753425917733531.
Jaitly V, Klein K, Tint H, Chen A, Allison P, Akkanti B,
. . .
Castillo B (2017) Intra-Pericardial Use of Recombinant
Factor VIIa in a Patient With Acute Hemorrhagic Pericardial Effusion Following
Transcutaneous Aortic Valve Replacement-A Case Report. Lab Med 48:262-265.
Kassem M, Niazi ZR, Abbas M, El Habhab A, Kreutter G,
Khemais-Benkhiat S, . . . Kessler L (2017) Senescence of Pancreas in
Middle-Aged Rats with Normal Vascular Function. Ann Transplant 22:177-186.
Keshava S, Sundaram J, Rajulapati A, Esmon C, Pendurthi
U, Rao LVM
(2017) Factor VIIa interaction with EPCR modulates the
hemostatic effect of rFVIIa in hemophilia therapy: Mode of its action. Blood
Adv 1:1206-1214.
Kotla S, Singh NK, Kirchhofer D, Rao GN (2017)
Heterodimers of the transcriptional factors NFATc3 and FosB mediate tissue
factor expression for 15(S)-hydroxyeicosatetraenoic acid-induced monocyte
trafficking. J Biol Chem 292:14885-14901.
Kovalenko TA, Panteleev MA, Sveshnikova AN (2017)
Substrate delivery mechanism and the role of membrane curvature in factor X
activation by extrinsic tenase. J Theor Biol 435:125-133.
Lohrmann GM, Atwal D, Augoustides JG, Askar W, Patel PA,
Ghadimi K, .
. . Ramakrishna H (2016) Reversal Agents for the New
Generation of Oral Anticoagulants: Implications for the Perioperative
Physician. J Cardiothorac Vasc Anesth 30:823-830.
Matus V, Valenzuela JG, Hidalgo P, Pozo LM, Panes O,
Wozniak A, . . .
Saez CG (2017) Human platelet interaction with E. coli
O111 promotes tissue-factor-dependent procoagulant activity, involving Toll
like receptor 4. PLoS One 12:e0185431.
Takashima H, Tsuji AB, Saga T, Yasunaga M, Koga Y, Kuroda
JI, . . .
Matsumura Y (2017) Molecular imaging using an anti-human
tissue factor monoclonal antibody in an orthotopic glioma xenograft model.
Sci Rep 7:12341.
Tong M, Wang J, Ji Y, Chen X, Wang J, Wang S, . . .
Watanabe E (2017) Effect of eicosapentaenoic acid and pitavastatin on
electrophysiology and anticoagulant gene expression in mice with rapid atrial
pacing.
Exp Ther Med 14:2310-2316.
Unruh D, Schwarze SR, Khoury L, Thomas C, Wu M, Chen L, .
. .
Horbinski C (2016) Mutant IDH1 and thrombosis in gliomas.
Acta Neuropathol 132:917-930.
Yasunaga M, Manabe S, Tsuji A, Furuta M, Ogata K, Koga Y,
. . .
Matsumura Y (2017) Development of Antibody-Drug
Conjugates Using DDS and Molecular Imaging. Bioengineering (Basel) 4.
Yuan Q, Zhang D, Wu S, Yu J, Yu L, Sun Y, . . . Hu J
(2017) FVIIa prevents the progressive hemorrhaging of a brain contusion by
protecting microvessels via formation of the TF-FVIIa-FXa complex.
Neuroscience 348:114-125.
Zhang X, Li Q, Zhao H, Ma L, Meng T, Qian J, . . . Yu K
(2017) Pathological expression of tissue factor confers promising antitumor
response to a novel therapeutic antibody SC1 in triple negative breast cancer
and pancreatic adenocarcinoma. Oncotarget 8:59086-59102.
Zhu S, Lu Y, Sinno T, Diamond SL (2016) Dynamics of
Thrombin Generation and Flux from Clots during Whole Human Blood Flow over
Collagen/Tissue Factor Surfaces. J Biol Chem 291:23027-23035.
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: James Morrissey, Dept.
of Biological Chemistry, University of Michigan Medical School, 4301E MSRB III
(Box 0600), 1150 West Medical Center Dr., Ann Arbor, MI 48109-5606, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes._________________________________
